Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
K Raghavendra Rao has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE16-07-2012
16-07-2012
Change in Directorate
Orchid Chemicals & Pharmaceuticals Ltd has informed BSE that Industrial Development Bank of India has withdrawn the nomination of Shri T. A. Ganesh and instead appointed Shri K. Biju George, Deputy General Manager, IDBI Bank Ltd, Chennai as its nominee on the Board of the Company with effect from June 06, 2012.12-06-2012
Auditors Report for March 31, 2012
Orchid Chemicals & Pharmaceuticals Ltd has submitted to BSE a Copy of the Auditors Report for the period ended March 31, 2012.05-06-2012
Allotment of Equity Shares
Orchid Chemicals & Pharmaceuticals Ltd has informed BSE that the Allotment Committee of the Board of Directors has allotted 10,000 equity shares of Rs. 10 each upon exercise of vested options by one of the employees under ESOP-2010 scheme on May 17, 2012.18-05-2012
Financial Results for March 31, 2012
Orchid Chemicals & Pharmaceuticals Ltd has informed BSE about the Financial Results for the period ended March 31, 2012.15-05-2012
Board recommends Dividend
Orchid Chemicals & Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 14, 2012, inter alia, recommended a Dividend of Rs. 3/- per share on the equity share of Rs. 10/- each.15-05-2012
Board to consider Dividend
Orchid Chemicals & Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 14, 2012, inter alia, to :1. approve the audited financial results of the Company for the financial year ended March 31, 2012.2. consider recommendation of dividend on equity capital for the financial year ended March 31, 2012.08-05-2012
Orchid Pharma receives US FDA approval for Naratriptan Tabs ANDA
Orchid Chemicals & Pharmaceuticals Ltd has informed BSE regarding a Press Release dated May 02, 2012 titled "Orchid Pharma receives US FDA approval for Naratriptan Tabs ANDA".Press Release :"The Chennai-based global pharma major, Orchid Chemicals & Pharmaceuticals Ltd (Orchid Pharma) today announced that it has received approval from the US FDA for its ANDA (Abbreviated New Drug Application) for Naratriptan Tablets in the 1 mg and...07-05-2012
Orchid Pharma receives US FDA approval for Olanzapine Tabs ANDA
Orchid Chemicals & Pharmaceuticals Ltd has informed BSE regarding a Press Release titled "Orchid Pharma receives US FDA approval for Olanzapine Tabs ANDA".Press Release:"The Chennai-based global pharma major, Orchid Chemicals & Pharmaceuticals Ltd (Orchid Pharma) today announced that it has received approval from the US FDA for its ANDA (Abbreviated New Drug Application) for Olanzapine Tablets in the 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15...28-04-2012
Update on Scheme of Amalgamation
Orchid Chemicals & Pharmaceuticals Ltd has informed BSE that the Honble High Court of Madras has sanctioned theScheme of Amalgamation for merger of Orchid Research Laboratories Limited with Orchid Chemicals & Pharmaceuticals Limited.04-04-2012